This inventor holds 3 USPTO granted patents and 5 published patent applications. Top assignee: Closed Loop Medicine Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Michael Catt in Drug Dosage Administration
Introduction
Michael Catt is an accomplished inventor based in Wellingborough, GB. He has made significant contributions to the field of medicine, particularly in the administration of drugs for the treatment of obesity and thrombosis. With a total of two patents to his name, Catt's work is paving the way for more effective patient care.
Latest Patents
Catt's latest patents include innovative methods for drug dosage administration. One of his patents focuses on the dosing of incretin pathway drugs, specifically a method for administering a dosage of Cagrisema to patients for obesity treatment. This method involves receiving patient data, including weight data, and utilizing a dosage calculator derived from a pharmacokinetic model to determine the appropriate dosage for each patient.
Another significant patent by Catt is related to Apixaban dosing. This method aims to administer a dosage of Apixaban for the treatment or prevention of thrombosis. It involves receiving patient data, particularly a kidney function metric, and processing this data with a dosage calculator that predicts Apixaban drug plasma levels. This personalized approach ensures that the dosage is tailored to the patient's specific needs.
Career Highlights
Michael Catt is currently associated with Closed Loop Medicine Ltd., where he continues to innovate in the field of drug administration. His work is characterized by a strong focus on patient-specific treatment plans, which enhance the effectiveness of medications.
Collaborations
Catt collaborates with notable professionals in his field, including Paul Goldsmith and Bruce Campbell. These partnerships contribute to the advancement of his research and the successful implementation of his patented methods.
Conclusion
Michael Catt's contributions to drug dosage administration represent a significant advancement in medical innovation. His patents not only enhance treatment efficacy but also prioritize patient safety and individualized care. Through his work, Catt is making a lasting impact on the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile